Antiaging Quantum Living Inc. (AAQL)
OTCMKTS · Delayed Price · Currency is USD
0.6038
-0.0962 (-13.74%)
At close: Jul 7, 2026
Antiaging Quantum Living Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.5 | 0.37 | 0.17 | 0 | 0.01 |
Cash & Short-Term Investments | 0.5 | 0.37 | 0.17 | 0 | 0.01 |
Cash Growth | 35.88% | 122.48% | 46948.59% | -97.52% | -18.44% |
Accounts Receivable | 0.03 | 0.09 | 0 | - | - |
Other Receivables | 0.17 | 0.17 | 0.03 | - | - |
Receivables | 0.2 | 0.25 | 0.03 | - | - |
Inventory | 0.22 | - | - | - | - |
Other Current Assets | 0.29 | 0.19 | 0.03 | - | - |
Total Current Assets | 1.21 | 0.81 | 0.22 | 0 | 0.01 |
Property, Plant & Equipment | 0.5 | 0.77 | 0.76 | 0 | 0 |
Other Intangible Assets | 0.01 | 0.01 | - | - | - |
Other Long-Term Assets | - | - | 0.03 | - | - |
Total Assets | 1.72 | 1.59 | 1.01 | 0 | 0.02 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.39 | 0.05 | 0.06 | 0 | - |
Current Portion of Long-Term Debt | 0.98 | 0.52 | 0.61 | 0.08 | 0.06 |
Current Portion of Leases | 0.05 | 0.05 | 0.18 | - | - |
Current Income Taxes Payable | 0 | 0 | 0 | - | - |
Current Unearned Revenue | 0.1 | 0.01 | - | 0 | 0.01 |
Other Current Liabilities | 0.15 | 0.05 | 0.01 | - | - |
Total Current Liabilities | 1.67 | 0.68 | 0.87 | 0.09 | 0.06 |
Long-Term Debt | 0.41 | 1.67 | - | - | - |
Long-Term Leases | 0.32 | 0.37 | 0.13 | - | - |
Other Long-Term Liabilities | - | - | 0.42 | - | - |
Total Liabilities | 2.4 | 2.72 | 1.43 | 0.09 | 0.06 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-In Capital | 1.53 | 0.24 | 0.24 | 0.16 | 0.16 |
Retained Earnings | -2.25 | -1.41 | -0.69 | -0.28 | -0.24 |
Comprehensive Income & Other | 0.01 | 0.01 | 0 | - | - |
Shareholders' Equity | -0.68 | -1.13 | -0.41 | -0.09 | -0.05 |
Total Liabilities & Equity | 1.72 | 1.59 | 1.01 | 0 | 0.02 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1.76 | 2.61 | 0.93 | 0.08 | 0.06 |
Net Cash (Debt) | -1.25 | -2.24 | -0.76 | -0.08 | -0.04 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.07 | -0.03 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 34.28 | 30 | 30 | 30 | 30 |
Total Common Shares Outstanding | 34.28 | 30 | 30 | 30 | 30 |
Working Capital | -0.46 | 0.13 | -0.65 | -0.09 | -0.05 |
Book Value Per Share | -0.02 | -0.04 | -0.01 | -0.00 | -0.00 |
Tangible Book Value | -0.69 | -1.14 | -0.41 | -0.09 | -0.05 |
Tangible Book Value Per Share | -0.02 | -0.04 | -0.01 | -0.00 | -0.00 |
Machinery | 0.07 | 0.02 | 0.01 | 0 | - |
Leasehold Improvements | 0.38 | 0.25 | 0.22 | - | - |